No Data
No Data
No Data
No Data
No Data
Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market
NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (NASDAQ:MCAG) (the "Company") announced today that it has received approval from the Nasdaq Stock Market ("Nasdaq") to transfer the listing
GlobeNewswireOct 25, 2023 09:00 ET
AUM Biosciences Terminates Merger With SPAC Mountain Crest V
Seeking AlphaJun 15, 2023 14:25 ET
Short Interest in Mountain Crest Acquisition Corp. V (NASDAQ:MCAG) Decreases By 16.7%
Mountain Crest Acquisition Corp. V (NASDAQ:MCAG – Get Rating) was the recipient of a significant decrease in short interest during the month of February. As of February 28th, there was short interest
Financial News LiveMar 15, 2023 09:38 ET
SPAC Mountain Crest III Shareholders Approve ETAO Merger
Seeking AlphaFeb 8, 2023 11:37 ET
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma
SINGAPORE and BETHESDA, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. ("AUM"), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced
GlobeNewswireJan 5, 2023 08:02 ET
AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma
SINGAPORE and BETHESDA, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. ("AUM"), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced
GlobeNewswireNov 30, 2022 08:05 ET
No Data
No Data